+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term efficacy and safety of varenicline for smoking cessation a systematic review and meta-analysis of randomized controlled trials



Long-term efficacy and safety of varenicline for smoking cessation a systematic review and meta-analysis of randomized controlled trials



Journal of Public Health 20(4): 355-365



To evaluate the long-term efficacy and potential risk of psychiatric side effects of varenicline for smoking cessation compared with placebo or nicotine replacement therapy. Subject and methods Systematic search of electronic databases (MEDLINE, EMBASE, Cochrane Central Register, SCI) up to March 21Two reviewers independently determined the eligibility of randomized controlled trials comparing varenicline with placebo, or nicotine replacement therapy with follow-up of at least 12 months. Information was independently extracted by 2 reviewers. Ten trials involving 6,375 smokers were included in the meta-analysis. The pooled risk ratios (RR) for continuous abstinence was 2.83 (95% CI: 2.2 3.63) at 52 weeks for varenicline (1 mg, twice per day) versus placebo. Varenicline seemed to be more effective in smokers with chronic obstructive pulmonary disease (RR, 3.33) than smokers with cardiovascular diseases (RR, 2.64) or health smokers (RR, 2.52), non-Asian smokers than Asian smokers (2.98 vs. 1.94), elder smokers than younger smokers (2.87 vs. 2.52), female smokers than male smokers (2.98 vs. 1.94). The five predominant reported adverse events for varenicline compared to placebo were vomiting, nausea, abnormal dreams, constipation, and dysgeusia. There was no sufficient evidence that varenicline was associated with an increased risk of psychiatric side effects (RR, 1.45, 95% CI: .9 2.32). Varenicline therapy compared with placebo is associated with a favorable effect on smoking cessation at the end of 52 weeks. However, the psychiatric adverse events related with varenicline should be further studied with larger qualified study. People with preexisting mental illnesses should be prudently treated with varenicline.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036306536

Download citation: RISBibTeXText

DOI: 10.1007/s10389-011-0476-5


Related references

Efficacy and safety of Vernonia cinerea (L.) Less. for smoking cessation: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine 37: 37-42, 2018

Efficacy and safety of Vernonia cinerea (L.) Less. for smoking cessation: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine 37: 37-42, 2018

Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials. Circulation. Cardiovascular Quality and Outcomes 10(1):, 2017

Bupropion for smoking cessation in patients hospitalized with cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Canadian Journal of Cardiology 29(12): 1704-1711, 2013

Safety and efficacy of the minilaparotomy for myomectomy: a systematic review and meta-analysis of randomized and non-randomized controlled trials. Reproductive Biomedicine Online 30(5): 462-481, 2015

Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials. Bmc Public Health 15: 689, 2015

Efficacy and safety of Tai Chi for Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. Plos one 9(6): E99377, 2014

Efficacy and safety of LCI699 for hypertension: a meta-analysis of randomized controlled trials and systematic review. European Review for Medical and Pharmacological Sciences 19(2): 296-304, 2015

Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials. Journal of Antimicrobial ChemoTherapy 60(2): 247-257, 2007

Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association 5(2):, 2016

Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials. Journal of the American Academy of Dermatology 80(5): 1435-1444, 2019

Efficacy and Safety of Cissus quadrangularis L. in Clinical Use: A Systematic Review and Meta-analysis of Randomized Controlled Trials. PhytoTherapy Research 31(4): 555-567, 2017

Efficacy and safety of benralizumab for eosinophilic asthma: A systematic review and meta-analysis of randomized controlled trials. Journal of Asthma 55(9): 956-965, 2018

The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials. Osteoporosis International 30(6): 1175-1186, 2019

Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis. Frontiers in Psychiatry 9: 428, 2018